N-Acetylcysteine in the prevention of contrast-induced nephropathy: Publication bias perpetuated by meta-analyses
- 28 February 2007
- journal article
- review article
- Published by Elsevier BV in American Heart Journal
- Vol. 153 (2), 275-280
- https://doi.org/10.1016/j.ahj.2006.09.014
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Publication bias and journals as policemenJournal of the American College of Cardiology, 2004
- Acetylcysteine, coronary procedure and prevention of contrast-induced worsening of renal functionActa Cardiologica, 2003
- The effect of N-acetylcysteine on renal function, nitric oxide, and oxidative stress after angiographyKidney International, 2003
- Prophylaxis of contrast‐induced nephropathy in patients undergoing coronary angiographyCatheterization and Cardiovascular Interventions, 2003
- Factors Associated With Failure to Publish Large Randomized Trials Presented at an Oncology MeetingJAMA, 2003
- A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID studyJournal of the American College of Cardiology, 2003
- A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiographyKidney International, 2002
- Prospective randomized study of N‐acetylcysteine, fenoldopam, and saline for prevention of radiocontrast‐induced nephropathyCatheterization and Cardiovascular Interventions, 2002
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996
- A GENERAL ESTIMATOR FOR THE VARIANCE OF THE MANTEL HAENSZEL ODDS RATIOAmerican Journal of Epidemiology, 1986